Global Herpes Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Published Report
  • Aug 2021
  • Global
  • 350 Pages
  • No of Tables: 331
  • No of Figures: 79

Global Herpes Market, By Virus Type (Herpes Simplex and Herpes Zoster), Product (Acyclovir, Docosanol, Valacyclovir, Famciclovir and Others), Drug Type (Prescription Drug and Over-the-counter Drug), Age (Adult and Pediatrics), Route Of Administration (Topical, Oral, and Parenteral), Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies, and Others), End Users (Hospitals, Speciality Clinics, and Others) Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, China, India, Japan, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, and Rest of Middle East and Africa) Industry Trends and Forecast to 2028.

Herpes Market Market Analysis and Insights: Global Herpes Market

Global herpes market is expected to gain significant growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyzes that the market is growing with a CAGR of 6.6% in the forecast period of 2021 to 2028 and is expected to reach USD 1,627.74 million by 2028 from USD 1020.91 million in 2020. Rising prevalence of herpes infections and increasing geriatric population are major drivers, which are expected to boost the growth of the market in the forecast period.

A growing number of people are affected with by the herpes simplex virus, which demands highly effective and advanced anti-herpetic treatment to minimize the risk during the treatment. The healthcare systems need highly advanced drugs for numerous different types of herpes during the treatment of patients. Therefore, major market players are highly focusing on product launches and product approvals. Additionally, governments and regulatory bodies are supporting market players by virtue of product approvals.

Rising prevalence of herpes diseases and increase in health expenditure across regions have accelerated the need for anti-herpetic drugs in healthcare facilities, which is driving the growth of the herpes market. In addition, surging volume of geriatric people is further propelling the market growth. However, high cost of anti-herpetic medicines and product recalls are anticipated to hinder market growth in the projected period. On the other hand, strategic initiatives by market players and soaring number of anti-herpetic drugs manufacturers act as an opportunity for this market and is expected to impel the market growth. However, disruption in supply chain of herpes drugs and injections during covid-19 and lack of workforce in pharma industries are key challenges for this market.

The global herpes market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyzes opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.   

Herpes Market Global Herpes Market Scope and Market Size

The global herpes market is segmented on the basis of virus type, product, drug type, age, route of administration, distribution channel, and end users. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of virus type, the global herpes market is segmented into herpes simplex and herpes zoster.  In 2021, herpes simplex segment is expected to dominate the market due to rise in prevalence of herpes infections due to unprotected sex with an infected partner.  
  • On the basis of product, the global herpes market is segmented into acyclovir, docosanol, valacyclovir, famciclovir, and others. In 2021, acyclovir segment is expected to dominate the market as it effectively lessens the infection symptoms and increases healthcare expenditure due to growing healthcare awareness among people.
  • On the basis of drug type, the global herpes market is segmented into prescription drug and over-the counter drug. In 2021, prescription drug segment is expected to dominate the market owing to rise in prevalence of viral diseases, such as HPV, HIV/AIDS and measles.
  • On the basis of age, the global herpes market is segmented into adult and pediatrics. In 2021, adult segment is expected to dominate the market owing to growing geriatric population due to the increasing life expectancy of people.
  • On the basis of route of administration, the global herpes market is segmented into topical, oral, and parenteral. In 2021, topical segment is expected to dominate the market as it is easy to use, non-invasive method with greater patient compliance.
  • On the basis of distribution channel, the global herpes market is segmented into hospitals pharmacies, retail pharmacies, drug stores, online pharmacies, and others. In 2021, hospital pharmacies segment is expected to dominate the market owing to evident presence of several major players in the market.
  • On the basis of end-users, the global herpes market is segmented into hospital, speciality clinics, and others. In 2021, hospitals segment is expected to dominate the market due to growing awareness among people about types of herpes virus and their treatment.

Herpes Market Global Herpes Market Country Level Analysis

The global herpes market is analyzed and market size information is provided based on virus type, product, drug type, age, route of administration, distribution channel, and end users. 

Regions covered in the global herpes market report are North America, Europe, Asia-Pacific, South America, and Middle East and Africa. These regions are further segmented into major countries such as the U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, China, India, Japan, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia Philippines, and Rest of Asia-Pacific, Brazil, Argentina and Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, and Rest of Middle East and Africa.

North America is expected to dominate the global herpes market due to increasing prevalence of herpes in the region and Asia-Pacific is expected to grow with the highest CAGR in the forecast period due to increasing healthcare expenditure in the region. The U.S. is dominating in the market and leading the growth in the global herpes market due to rising herpes infections in the region. The Asia-Pacific region is expected to grow with the most promising growth rate in the forecast period of 2021 to 2028 because of rising prevalence of geriatric population China, Japan, and India. China is dominating the Asia-Pacific market due to rising disposable income in the country. The market in Europe is expected to grow significantly in the forecast period of 2021 to 2028 due to technological advancements in the region. Germany is dominating the European market owing to large number of players in the market.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.  

Rising healthcare expenditure and high prevalence of herpes infections in the global herpes market are creating new opportunities for players

The route of administration segment in the U.S. is expected to grow with the highest rate and it is dominating the North America region in the forecast period of 2021 to 2028 because of rising prevalence of herpes infections. Germany is leading the market in Europe region and herpes simplex segment is dominating the country due to rising demand for anti- herpetic drugs. In addition, herpes simplex segment is dominating in China, which is leading in the Asia-Pacific region owing to growing geriatric population in the country.

Global herpes market also provides you with detailed market analysis for every country growth in particular industry with the Global herpes market sales, impact of advancement in the Global herpes market and changes in regulatory scenarios with their support for the global herpes market. The data is available for historic period 2010 to 2018. 

Competitive Landscape and Global herpes market Share Analysis

Global herpes market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, and technology lifeline curve. The above data points provided are only related to the companies’ focus related to global herpes market.

Major players covered in the report are Abbott, Apotex, Inc., Avet Pharmaceuticals, Inc., Bausch Health Companies, Inc. Cipla, Inc., Dr. Reddy’s Laboratories Ltd., EPI Health, Fresenius Kabi AG, GlaxoSmithKline plc., Glenmark Pharmaceutical Inc., USA, Maruho Co.,Ltd.,  Mylan N.V.,  Pfizer Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Zydus Pharmaceuticals, Inc., RECORDATI S.p.A., Aurobindo Pharma, Amneal Pharmaceuticals LLC, Slavia Pharm S.R.L., and Blistex, Inc., among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launches and agreements are also initiated by the companies worldwide, which are further accelerating the growth of the global herpes market.

For instance,

  • In November 2019, Mylan N.V. announced collaboration with Upjohn, a division of Pfizer, the new company formed would be named Viatris. The merger of both the companies to develop a combined firm has expanded their product portfolio, leading to increased demand for their products in the market.
  • In September 2018, Avet Pharmaceuticals Inc. announced immediate availability of Acyclovir 200 mg Capsules. This launch enhanced Avet’s broad portfolio of generic oral solid products. This new drug launched by the company has increased its demand in the market, leading to increased revenue in the future.

Customization Available: Global Herpes Market  

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES 

TABLE 1 THE EMA HAS SEVEN SCIENTIFIC COMMITTEES THAT CARRY OUT ITS SCIENTIFIC ASSESSMENTS:

TABLE 2 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC

TABLE 3 MANUFACTURERS OF ANTI-HERPETIC DRUGS

TABLE 4 GLOBAL HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 5 GLOBAL HERPES SIMPLEX IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 6 GLOBAL HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 7 GLOBAL HERPES ZOSTER IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 8 GLOBAL HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 9 GLOBAL ACYCLOVIR IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 GLOBAL DOCOSANOL IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 GLOBAL VALACYCLOVIR IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 GLOBAL FAMCICLOVIR IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 GLOBAL OTHERS IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 GLOBAL HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 15 GLOBAL PRESCRIPTION DRUG IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 GLOBAL OVER-THE COUNTER DRUG IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 GLOBAL HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 18 GLOBAL ADULT IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 19 GLOBAL PEDIATRICS IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 GLOBAL HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 21 GLOBAL TOPICAL IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 GLOBAL ORAL IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 GLOBAL PARENTERAL IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 GLOBAL HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 25 GLOBAL HOSPITALS PHARMACIES IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 GLOBAL RETAIL PHARMACIES IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 GLOBAL DRUG STORES IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 GLOBAL ONLINE PHARMACIES IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 GLOBAL OTHERS IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 GLOBAL HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 31 GLOBAL HOSPITALS IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 GLOBAL SPECIALITY CLINICS IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 33 GLOBAL OTHERS IN HERPES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 34 GLOBAL HERPES MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 35 NORTH AMERICA HERPES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 36 NORTH AMERICA HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 37 NORTH AMERICA HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 38 NORTH AMERICA HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 39 NORTH AMERICA HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 40 NORTH AMERICA HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 41 NORTH AMERICA HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 42 NORTH AMERICA HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 43 NORTH AMERICA HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 44 U.S. HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 45 U.S. HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 46 U.S. HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 47 U.S. HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 48 U.S. HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 49 U.S. HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 50 U.S. HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 51 U.S. HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 52 CANADA HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 53 CANADA HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 54 CANADA HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 55 CANADA HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 56 CANADA HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 57 CANADA HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 58 CANADA HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 59 CANADA HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 60 MEXICO HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 61 MEXICO HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 62 MEXICO HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 63 MEXICO HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 64 MEXICO HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 65 MEXICO HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 66 MEXICO HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 67 MEXICO HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 68 EUROPE HERPES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 69 EUROPE HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 70 EUROPE HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 71 EUROPE HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 72 EUROPE HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 73 EUROPE HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 74 EUROPE HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 75 EUROPE HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 76 EUROPE HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 77 GERMANY HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 78 GERMANY HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 79 GERMANY HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 80 GERMANY HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 81 GERMANY HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 82 GERMANY HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 83 GERMANY HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 84 GERMANY HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 85 FRANCE HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 86 FRANCE HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 87 FRANCE HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 88 FRANCE HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 89 FRANCE HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 90 FRANCE HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 91 FRANCE HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 92 FRANCE HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 93 U.K. HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 94 U.K. HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 95 U.K. HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 96 U.K. HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 97 U.K. HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 98 U.K. HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 99 U.K. HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 100 U.K. HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 101 ITALY HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 102 ITALY HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 103 ITALY HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 104 ITALY HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 105 ITALY HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 106 ITALY HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 107 ITALY HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 108 ITALY HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 109 SPAIN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 110 SPAIN HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 111 SPAIN HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 112 SPAIN HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 113 SPAIN HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 114 SPAIN HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 115 SPAIN HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 116 SPAIN HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 117 RUSSIA HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 118 RUSSIA HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 119 RUSSIA HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 120 RUSSIA HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 121 RUSSIA HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 122 RUSSIA HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 123 RUSSIA HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 124 RUSSIA HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 125 TURKEY HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 126 TURKEY HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 127 TURKEY HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 128 TURKEY HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 129 TURKEY HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 130 TURKEY HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 131 TURKEY HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 132 TURKEY HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 133 BELGIUM HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 134 BELGIUM HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 135 BELGIUM HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 136 BELGIUM HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 137 BELGIUM HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 138 BELGIUM HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 139 BELGIUM HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 140 BELGIUM HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 141 NETHERLANDS HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 142 NETHERLANDS HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 143 NETHERLANDS HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 144 NETHERLANDS HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 145 NETHERLANDS HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 146 NETHERLANDS HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 147 NETHERLANDS HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 148 NETHERLANDS HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 149 SWITZERLAND HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 150 SWITZERLAND HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 151 SWITZERLAND HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 152 SWITZERLAND HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 153 SWITZERLAND HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 154 SWITZERLAND HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 155 SWITZERLAND HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 156 SWITZERLAND HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 157 LUXEMBURG HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 158 LUXEMBURG HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 159 LUXEMBURG HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 160 LUXEMBURG HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 161 LUXEMBURG HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 162 LUXEMBURG HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 163 LUXEMBURG HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 164 LUXEMBURG HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 165 REST OF EUROPE HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 166 ASIA-PACIFIC HERPES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 167 ASIA-PACIFIC HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 168 ASIA-PACIFIC HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 169 ASIA-PACIFIC HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 170 ASIA-PACIFIC HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 171 ASIA-PACIFIC HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 172 ASIA-PACIFIC HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 173 ASIA-PACIFIC HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 174 ASIA-PACIFIC HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 175 CHINA HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 176 CHINA HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 177 CHINA HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 178 CHINA HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 179 CHINA HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 180 CHINA HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 181 CHINA HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 182 CHINA HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 183 INDIA HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 184 INDIA HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 185 INDIA HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 186 INDIA HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 187 INDIA HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 188 INDIA HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 189 INDIA HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 190 INDIA HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 191 JAPAN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 192 JAPAN HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 193 JAPAN HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 194 JAPAN HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 195 JAPAN HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 196 JAPAN HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 197 JAPAN HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 198 JAPAN HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 199 SOUTH KOREA HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 200 SOUTH KOREA HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 201 SOUTH KOREA HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 202 SOUTH KOREA HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 203 SOUTH KOREA HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 204 SOUTH KOREA HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 205 SOUTH KOREA HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 206 SOUTH KOREA HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 207 AUSTRALIA HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 208 AUSTRALIA HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 209 AUSTRALIA HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 210 AUSTRALIA HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 211 AUSTRALIA HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 212 AUSTRALIA HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 213 AUSTRALIA HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 214 AUSTRALIA HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 215 SINGAPORE HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 216 SINGAPORE HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 217 SINGAPORE HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 218 SINGAPORE HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 219 SINGAPORE HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 220 SINGAPORE HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 221 SINGAPORE HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 222 SINGAPORE HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 223 THAILAND HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 224 THAILAND HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 225 THAILAND HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 226 THAILAND HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 227 THAILAND HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 228 THAILAND HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 229 THAILAND HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 230 THAILAND HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 231 MALAYSIA HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 232 MALAYSIA HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 233 MALAYSIA HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 234 MALAYSIA HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 235 MALAYSIA HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 236 MALAYSIA HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 237 MALAYSIA HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 238 MALAYSIA HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 239 INDONESIA HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 240 INDONESIA HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 241 INDONESIA HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 242 INDONESIA HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 243 INDONESIA HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 244 INDONESIA HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 245 INDONESIA HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 246 INDONESIA HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 247 PHILIPPINES HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 248 PHILIPPINES HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 249 PHILIPPINES HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 250 PHILIPPINES HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 251 PHILIPPINES HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 252 PHILIPPINES HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 253 PHILIPPINES HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 254 PHILIPPINES HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 255 REST OF ASIA-PACIFIC HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 256 SOUTH AMERICA HERPES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 257 SOUTH AMERICA HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 258 SOUTH AMERICA HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 259 SOUTH AMERICA HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 260 SOUTH AMERICA HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 261 SOUTH AMERICA HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 262 SOUTH AMERICA HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 263 SOUTH AMERICA HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 264 SOUTH AMERICA HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 265 BRAZIL HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 266 BRAZIL HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 267 BRAZIL HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 268 BRAZIL HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 269 BRAZIL HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 270 BRAZIL HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 271 BRAZIL HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 272 BRAZIL HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 273 ARGENTINA HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 274 ARGENTINA HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 275 ARGENTINA HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 276 ARGENTINA HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 277 ARGENTINA HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 278 ARGENTINA HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 279 ARGENTINA HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 280 ARGENTINA HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 281 REST OF SOUTH AMERICA HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 282 MIDDLE EAST AND AFRICA HERPES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 283 MIDDLE EAST AND AFRICA HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 284 MIDDLE EAST AND AFRICA HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 285 MIDDLE EAST AND AFRICA HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 286 MIDDLE EAST AND AFRICA HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 287 MIDDLE EAST AND AFRICA HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 288 MIDDLE EAST AND AFRICA HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 289 MIDDLE EAST AND AFRICA HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 290 MIDDLE EAST AND AFRICA HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 291 SOUTH AFRICA HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 292 SOUTH AFRICA HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 293 SOUTH AFRICA HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 294 SOUTH AFRICA HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 295 SOUTH AFRICA HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 296 SOUTH AFRICA HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 297 SOUTH AFRICA HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 298 SOUTH AFRICA HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 299 SAUDI ARABIA HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 300 SAUDI ARABIA HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 301 SAUDI ARABIA HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 302 SAUDI ARABIA HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 303 SAUDI ARABIA HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 304 SAUDI ARABIA HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 305 SAUDI ARABIA HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 306 SAUDI ARABIA HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 307 U.A.E. HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 308 U.A.E. HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 309 U.A.E. HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 310 U.A.E. HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 311 U.A.E. HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 312 U.A.E. HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 313 U.A.E. HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 314 U.A.E. HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 315 EGYPT HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 316 EGYPT HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 317 EGYPT HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 318 EGYPT HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 319 EGYPT HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 320 EGYPT HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 321 EGYPT HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 322 EGYPT HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 323 ISRAEL HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 324 ISRAEL HERPES SIMPLEX IN HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

TABLE 325 ISRAEL HERPES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 326 ISRAEL HERPES MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 327 ISRAEL HERPES MARKET, BY AGE, 2019-2028 (USD MILLION)

TABLE 328 ISRAEL HERPES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 329 ISRAEL HERPES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 330 ISRAEL HERPES MARKET, BY END USERS, 2019-2028 (USD MILLION)

TABLE 331 REST OF MIDDLE EAST AND AFRICA HERPES MARKET, BY VIRUS TYPE, 2019-2028 (USD MILLION)

 

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions